Two prices, and the footnote that connects them
LifeMD prints self-pay figures for the Zepbound vial and for both Wegovy forms on its main weight management page. Then it prints a footnote saying those figures exclude the monthly program and provider fee.
That footnote does the work. Plenty of sellers here bury the same fact at checkout or leave a reader to discover it on the second bill. LifeMD puts it under the number.
So a month at LifeMD is two charges. The medication, and the program fee. Neither one is optional if you want the other.
The self-pay figures carry a condition
LifeMD's footnote says the advertised medication prices are for new patients who are eligible for a prescription without insurance coverage.
That is narrower than a plain cash price. It describes a specific starting situation, not a standing rate available to anyone who signs up.
If you have coverage, you are on a different path with a different number attached. If you are not new, ask whether the advertised figure still applies to you before assuming it does.
The program fee is the recurring decision
The first month of the program fee is discounted. After that it renews at a standing rate that is larger than the cheapest medication figure on the page.
That inverts what most readers expect. At LifeMD, for the least expensive product, the service costs more than the drug. Budget from the second month, because the first one is not representative.
LifeMD says the program can be cancelled at any time, which is worth more here than it would be at a seller demanding a year up front. The exit is the thing that makes a high recurring fee survivable.
It tells the truth about the copay number
LifeMD advertises a very low copay range for patients whose insurance covers a GLP-1. It also states what that figure actually is: an average across its patients who were approved and had coverage.
That single sentence is the most reader-respecting thing on the page. An average across the people who succeeded is not a price. It excludes everyone who was denied, and it excludes anyone whose plan does not cover weight-loss medication at all.
Most sellers advertising a coverage-dependent figure do not explain it that carefully. Read the low number as the outcome for people it worked for, and price your decision on the self-pay figures instead.
What is not on the page
LifeMD does not publish which states it treats. No coverage statement appears on the weight management page.
It does not name a pharmacy either, though that matters less here than it would at a compounded seller, because these are the manufacturers' finished products.
The medication figures themselves match what several other brand-name sellers in this comparison publish. As with the rest of that group, the program fee is where LifeMD actually differs from its competitors.
LifeMD's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (brand) | $199/mo"Wegovy® Pen Starting At Just $199". LifeMD's own footnote: "Initial Wegovy® / Ozempic® pricing starting at $199 (pen) and $149 (Wegovy® pill) is for new patients eligible for prescription without insurance coverage. Price does not include the monthly program & provider fee of $149 (first month discounted to $39 today)." | September 2026source |
| Semaglutide (brand) | $149/mo"$149 (Wegovy® pill)" for new patients without insurance coverage; the same footnote states the price excludes the $149 monthly program and provider fee | September 2026source |
| Tirzepatide (brand) | $299/mo"Zepbound® Vial Starting At $299", excluding the monthly program and provider fee | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 38 providers reviewed here are paid partners today; the other 34 are not. See how this works.
See LifeMD's current price →Good fit if
- Readers who want an FDA-approved GLP-1 and want the recurring service fee stated in the same breath as the drug price.
- Patients with insurance who want help pursuing coverage, told plainly what the advertised copay figure represents.
- Buyers who want the option to cancel monthly rather than commit to a year to reach a better rate.
- New self-pay patients, since the advertised medication figures are written for exactly that situation.
Look elsewhere if
- Anyone reading the medication figure as the total. The program fee renews at a rate larger than the cheapest drug price on the page.
- Buyers counting on the low copay figure. It is an average across patients who were approved and covered, not a rate on offer.
- Readers who want one all-in monthly charge with no separate service fee. Gala GLP-1 prices its compounded plan that way.
- Patients who need their state confirmed from the site before starting, since LifeMD publishes no coverage statement.
How this review was verified
- Read the weight management page at its own source URL and logged all three published self-pay figures with the date each was read.
- Quoted LifeMD's own footnote into the qualifier on each figure, including the new-patient and no-coverage condition attached to the advertised prices.
- Recorded the program and provider fee as a separate charge, with its discounted first month and its standing rate both written into the qualifier.
- Recorded LifeMD's own description of the copay figure as an average across approved and covered patients, rather than logging it as an available rate.
- Checked the weight management page for a statement of served states and left the field unpublished instead of assuming nationwide coverage.